According to Drug Alert, Actos has been banned overseas but the U.S. continues to only issue a safety warning. Although France and Germany banned the diabetes drug that has been linked to bladder cancer, the U.S. Food and Drug...
Actos Linked To Bladder Cancer
On June 15, 2011, the FDA released a safety announcement concerning the use of Actos (pioglitazone) and bladder cancer. This warning is following a review of data from a ten-year study of the drug by the manufacturer, Takeda Pharmaceuticals. ...
Diabetes Drug Actos Linked to Bladder Cancer
Actos is a prescription diabetes drug (generically known as pioglitazone) linked to bladder cancer by both the FDA as well as the European Medicines Agency (EMA). Actos is manufactured by Takeda Pharmaceuticals, Inc. in Japan and was approved by...